Professor Wassersug's research focuses on developing ways to help patients recognize and overcome the side effects of prostate cancer (PCa) treatments. His primary attention is on androgen deprivation therapy (ADT), the common treatment for advanced prostate cancer in both Canada and Australia. ADT has been increasingly shown to have not only d...
World Urology Congress